News RS Oncology Announces New Preclinical Data Show RSO-021 May Block and/or Reverse the Progression of Aggressive Mesotheliomas, Improving Druggability Sep 13, 2023
News RS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreversible Inhibitor of Mitochondrial PRX3 Sep 12, 2023
News BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting Sep 07, 2023 Posted by BioIVT
Case Studies Expedite Training, Technical Support, and Lab Design by Leveraging Mixed Reality Sep 06, 2023
News Greenberg Traurig’s Melissa Hunter-Ensor and Chia-Feng Lu Shortlisted for LMG Life Sciences 2023 Americas Awards Aug 29, 2023 Posted by Greenberg Traurig, LLP
.png)
